error code: 523 Burjeel Cancer Institute Forges Global Collaborations to Enhance Cancer Care in the Region – Health – Newsglobalarena

Burjeel Cancer Institute Forges Global Collaborations to Enhance Cancer Care in the Region – Health

In a serious step towards increasing entry to world-class oncology providers, Burjeel Most cancers Institute (BCI), one of many largest most cancers care networks within the UAE, has introduced strategic collaborations with three globally famend establishments — the European Institute of Oncology (IEO), the Kids’s Hospital of Philadelphia (CHOP), and SJD Barcelona Kids’s Hospital — throughout Abu Dhabi International Healthcare Week. These partnerships purpose to redefine oncology care within the area by advancing medical providers, analysis, schooling, and personalised oncology.

BCI caters to over 5,000 sufferers every year and offers 360-degree tailor-made care, from prognosis to survivorship packages. Its community is unfold throughout the complete UAE, together with key areas in Abu Dhabi, Al Ain, Dubai, Sharjah, and Al Dhafra, guaranteeing entry to complete and compassionate most cancers care throughout all ages.

These new collaborations will leverage teleconsultation and distant affected person monitoring applied sciences, facilitate second opinions from worldwide specialists, and set up visiting packages to allow deeper data trade and improve native capabilities.

Enhancing Pediatric Most cancers Care

The Kids’s Hospital of Philadelphia (CHOP) collaboration will improve pediatric most cancers care and strengthen capabilities in superior diagnostics, distant consultations, and multidisciplinary second opinions. Visiting packages from CHOP will assist data trade in subspecialized pediatric oncology.

Mrs. Madeline Bell – President & Chief Govt Officer (CEO) for Kids’s Hospital of Philadelphia (CHOP), mentioned “We’re excited to collaborate with BCI in advancing pediatric most cancers care by shared experience, distant care improvements, and coaching alternatives. Collectively, we’ll empower healthcare groups and assist households dealing with childhood most cancers.”

The partnership with SJD Barcelona Kids’s Hospital is about to additional increase BCI’s capabilities in complete childhood most cancers care. The collaboration will provide steady distant assist and medical steering, notably for uncommon and sophisticated pediatric circumstances.

Dr. Manel del Castillo Rey – Chief Govt Officer (CEO) SJD Barcelona Kids’s Hospital, commented, “Our collaboration with BCI offers a framework for sharing specialised data and co-managing advanced pediatric oncology circumstances. By bridging geographies, we are able to present extra kids with entry to knowledgeable care.”

Integrating International Experience

In partnership with the European Institute of Oncology (IEO), BCI will give attention to strengthening most cancers care within the UAE by medical and scientific analysis growth, coaching and teaching programs for healthcare professionals, and high-level medical providers. The collaboration will even assist the creation of a distinguished community of visiting professors, capacity-building initiatives for nurses and pharmacists, and the institution of a strategic advisory board for BCI.

Ing. Mauro Melis – Chief Govt Officer IEO & Centro Cardiologico Monzino, mentioned, “Our partnership with Burjeel Most cancers Institute displays a shared dedication to elevating requirements in most cancers care. Via collaborative analysis, medical exchanges, and capacity-building, we purpose to collectively speed up innovation and enhance outcomes for sufferers within the nation and throughout the area.”

Advancing Diagnostic Testing for Most cancers

Along with these collaborations, Burjeel Most cancers Institute additionally joined palms with AbbVie Biopharmaceuticals to advance a personalised medication strategy in most cancers care. The collaboration goals to assist the adoption and entry to the most recent testing methods to boost the prognosis and therapy of sufferers with varied varieties of most cancers, together with ovarian, lung, and colorectal malignancies.

As a part of this initiative, the anatomical pathology laboratory lead by Dr. Rawia Mubarak will introduce a check for the primary time within the area for platinum-resistant ovarian most cancers, which is able to assist establish sufferers who could profit from rising focused therapies—providing a extra personalised path ahead and renewed hope for higher outcomes.

Mr. Mohammad Aboubakr Abdulgawad Mohammad – Normal Supervisor for AbbVie Prescribed drugs, mentioned,“Via our collaboration with Burjeel Most cancers Institute, we’re proud to introduce this superior check within the UAE, a vital step towards figuring out people who could profit from rising focused therapies. By adopting this innovation, physicians can provide a extra personalised and efficient strategy to care.”

Prof. Humaid Al Shamsi, CEO of Burjeel Most cancers Institute, remarked, “These international partnerships are a pivotal step in our mission to deliver world-class most cancers care to the area. By aligning with among the most prestigious establishments worldwide, we’re constructing a future-ready oncology ecosystem that prioritizes high quality, entry, and innovation for each affected person we serve.”

These partnerships underscore BCI’s strategic imaginative and prescient to not solely increase its medical capabilities but additionally function a regional hub for data, innovation, and excellence in oncology.

Leave a Reply

Your email address will not be published. Required fields are marked *